Individuals carrying the CYP1A1 AG (Ile/Val) genotype or the G/G, Val/Val genotype demonstrated a 23-fold and 18-fold increased susceptibility to developing CML, respectively [105]. This evidence concerns the gene CYP1A1 and chronic myelogenous leukemia, BCR-ABL1 positive.